This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Alomone Labs
product type :
chemical
product name :
Isradipine
catalog :
I-100
quantity :
5 mg, 10 mg, 25 mg, 50 mg
citations: 1
Reference
Dickerson M, Dadi P, Altman M, Verlage K, Thorson A, Jordan K, et al. Glucose-mediated inhibition of calcium-activated potassium channels limits α-cell calcium influx and glucagon secretion. Am J Physiol Endocrinol Metab. 2019;316:E646-E659 pubmed publisher
product information
Vendor :
Alomone Labs Ltd.
Item Name :
Isradipine
Catalog Number :
I-100
Size :
5 mg, 10 mg, 25 mg, 50 mg
Type :
Antagonists Inhibitors
Molecule Name :
4-(2,1,3-Benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylic acid methyl 1-methylethyl ester.
CAS Number :
75695-93-1
Source/Expression System :
Synthetic
Activity :
Isradipine is a dihydropyridine that acts as a L-type, voltage-gated Ca2+ channel blocker and is used in the clinic to treat hypertension. Isradipine inhibits L-type channels expressed in xenopus /em oocytes with IC50 = 0.2 muM at a holding potential of -80 mV and the inhibition is state dependent and increases with reduced membrane hyperpolarization. Isradipine, was also shown recently to putatively be an effective treatment for Parkinson’s disease, by affecting particularly the excitability of certain Cav1.3 expressing dopaminergic neurons.
Molecular Weight :
371.4
Gene symbol :
CACNA1C, CACNA1D
Target :
Cav1.2, Cav1.3 Ca2+ channels
Formula :
C19H21N3O5
Format :
Lyophilized/solid.
Purity :
99%
Product Description :
A Potent Blocker of L-Type (both Cav1.2 and Cav1.3) Ca+ Channels
Category :
Ca2+ signaling, Ca2+ signalling, Ion Channels, Chemicals and Reagents, Inhibitors, Biomolecules, Blockers, Antagonists
Research Area :
Cardiovascular, Cardiac, Heart, Alzheimer's Disease, Neurodegenerative Disorders, Neuroscience
company information
Alomone Labs
Jerusalem BioPark (JBP), Hadassah Ein Kerem
P.O. Box 4287
Jerusalem 9104201
info@alomone.com
http://www.alomone.com
972 2 531 8002
headquarters: Israel